PGAM5 overexpression at the RNA and protein level is associated with a bad prognosis in prostate cancer [194], lung adenocarcinoma [190], HCC [186,187,188,214], colon cancer [193], melanoma [191], and non-small cell lung cancer [192]. This evidence concerns the gene PGAM5 and hepatocellular carcinoma.